Rybelsus Tablets 3mg, from Novo Nordisk Pharma, contain Semaglutide (genetical recombination) and are used to treat adults with type 2 diabetes. This medication helps improve glycemic control by stimulating insulin secretion, lowering glucagon secretion, and delaying gastric emptying. YJ code: 2499014F1021, Standard: 3mg 1 tablet.
Rybelsus Tablets 3mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →